Davita - Highland County Dialysis in Hillsboro, Ohio - Dialysis Center

Davita - Highland County Dialysis is a medicare approved dialysis facility center in Hillsboro, Ohio and it has 9 dialysis stations. It is located in Highland county at 120 Roberts Lane, Suite 4, Hillsboro, OH, 45133. You can reach out to the office of Davita - Highland County Dialysis at (937) 393-3852. This dialysis clinic is managed and/or owned by Davita. Davita - Highland County Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 2010. The medicare id for this facility is 362750 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameDavita - Highland County Dialysis
Location120 Roberts Lane, Suite 4, Hillsboro, Ohio
No. of Dialysis Stations 9
Medicare ID362750
Managed ByDavita
Ownership TypeProfit
Late Shifts Yes

Contact Information


120 Roberts Lane, Suite 4, Hillsboro, Ohio, 45133
(937) 393-3852

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita - Highland County Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1083927024
Organization NameHighland County Dialysis
Doing Business AsTotal Renal Care Inc
Address120 Roberts Ln Ste 4 Hillsboro, Ohio, 45133
Phone Number(937) 393-3852

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago


NPI Number1669616108
Organization NameHighland County Dialysis
Doing Business AsMorro Dialysis Llc
Address120 Roberts Ln Hillsboro, Ohio, 45133
Phone Number(937) 393-3852

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data9

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center15
    Adult patient months included in Kt/V greater than or equal to 1.2116
    Percentage of adult patients getting regular hemodialysis at the center94
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

    Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

    Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

    Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

    Scientists investigate how T cells in colorectal tumors actively fight cancer

    In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

    BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

    Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

    Read more Medical News

    › Verified 4 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center2
    Adult patient months included in Kt/V greater than or equal to 1.724
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

    Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

    Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

    Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

    Scientists investigate how T cells in colorectal tumors actively fight cancer

    In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

    BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

    Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

    Read more Medical News

    › Verified 4 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Highland County Dialysis with elevated calcium levels.

Patients with hypercalcemia19
Hypercalcemia patient months174
Patients with Serumphosphor21
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL33
Patients with Serumphosphor from 4.6 to 5.5 mg/dL27
Patients with Serumphosphor from 5.6 to 7 mg/dL21
Patients with Serumphosphor greater than 7 mg/dL13

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 14
Patient months included in arterial venous fistula and catheter summaries 96
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment60
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer19

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary20
Hospitalization Rate in facility215.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit497.6
Hospitalization Rate: Lower Confidence Limit99.9

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Davita - Highland County Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27.4 (As Expected)
Readmission Rate: Upper Confidence Limit41.9
Readmission Rate: Lower Confidence Limit15.1

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Highland County Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.7 (As Expected)
SIR: Upper Confidence Limit3.43
SIR: Lower Confidence Limit.04

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Highland County Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 17
Transfusion Rate in facility28.7 (As Expected)
Transfusion Rate: Upper Confidence Limit220.5
Transfusion Rate: Lower Confidence Limit4.8

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Davita - Highland County Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary117
Mortality Rate in facility22.7 (As Expected)
Mortality Rate: Upper Confidence Limit33.8
Mortality Rate: Lower Confidence Limit14.6

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago


Dialysis Facility in Hillsboro, OH

Davita Hillsboro Regional Dialysis
Location: 1487 North High Street, Unit 1a, Hillsboro, Ohio, 45133
Phone: (937) 393-9020
Davita - Highland County Dialysis
Location: 120 Roberts Lane, Suite 4, Hillsboro, Ohio, 45133
Phone: (937) 393-3852

News Archive

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

Scientists investigate how T cells in colorectal tumors actively fight cancer

In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is a good chance that the disease will take a favorable course and that the risk of metastasis is comparatively low.

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

Read more Medical News

› Verified 4 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.